Amyloid-Beta 3 Antibody | 39-850

Amyloid-Beta 3 Antibody | 39-850 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human, Bovine, Sheep, Non-Human Primate

Homology: N/A

Immunogen: A synthetic peptide corresponding to the N-terminus 3-pyro E start point.

Research Area: Neuroscience

Tested Application: E, WB, IHC

Application: ELISA, Western (immuno) blotting (in testing) , Immunostaining (in testing)

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Affinity Purified

Clonality: Polyclonal

Clone: N/A

Isotype: IgG

Conjugate: Unconjugated

Physical State: Liquid

Buffer: N/A

Concentration: N/A

Storage Condition: N/A

Alternate Name: Amyloid-Beta 3-pyr E, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma, A4

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: Pyro-glutamic acid truncated amyloid beta 3-40/42 may have a greater propensity to aggregate under physiological conditions. In addition, this pyro E modification has been implicated as the molecular species responsible for seeding larger oligomers of amyloid-β. Pyro-glutamic acid truncated amyloid beta 3-40/42’s exact involvement in the pathophysiology of Alzheimer’s disease has not been established.